American Journal of Kidney Diseases
Volume 51, Issue 3 , Pages 353-357 , March 2008

CKD in the Elderly—Old Questions and New Challenges: World Kidney Day 2008

  • Lesley A. Stevens, MD, MS

      Affiliations

    • Tufts–New England Medical Center, Boston, Massachusetts
    • Corresponding Author InformationAddress correspondence to Lesley A. Stevens, MD, Department of Nephrology, Tufts-New England Medical Center, 750 Washington St, Boston, MA 02111.
    • ,
  • Josef Coresh, MD, PhD

      Affiliations

    • Johns Hopkins Medical Institutions, Baltimore, Maryland
    • ,
  • Andrew S. Levey, MD

      Affiliations

    • Tufts–New England Medical Center, Boston, Massachusetts

References 

  1. Levey A, Andreoli S, DuBose T, Provenzano R, Collins AJ. CKD: Common, harmful, and treatable—World Kidney Day 2007. Am J Kidney Dis. 2007;49:175–179
  2. Centers for Disease Control and Prevention. Public health and aging: Trends in aging—United States and worldwide. MMWR Morb Mortal Wkly Rep. 2003;52:101–106
  3. Reed D, Foley D, White L, et al. Predictors of healthy aging in men with high life expectancies. Am J Public Health. 1998;88:1463–1468
  4. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–2047
  5. Levey AS, Greene T, Stevens LA, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254
  6. Zhang L, Zhang P, Wang F, et al. Prevalence and factors associated with CKD: A population study from Beijing. Am J Kidney Dis. 2008;51:373–384
  7. Ma Y-C, Zuo L, Chen J-H, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937–2944
  8. Stevens LA, Coresh J, Deysher AE, et al. Evaluation of the MDRD study equation in a large diverse population. J Am Soc Nephrol. 2007;18:2749–2757
  9. Coresh J, Stevens LA, and Levey AS: Chronic kidney disease is common: What do we do next? Nephrol Dial Transplant (in press)
  10. Couser WG. Chronic kidney disease the promise and the perils. J Am Soc Nephrol. 2007;18:2803–2805
  11. Glassock R, Winearls C: Epidemic of chronic kidney disease: fact or fiction. Nephrol Dial Transplant (in press)
  12. Wesson L. Physiology of the Human Kidney. New York: Grune & Stratton; 1969;
  13. Davies D, Shock N. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest. 1950;29:496–507
  14. Lindeman R, Tobin J, Shock N. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985;33:278–285
  15. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative Am J Kidney Dis. 2002;39(suppl 1):S1–S266
  16. Kasiske B. Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int. 1987;31:1153–1159
  17. Anderson S, Brenner B. Effects of aging on the renal glomerulus. Am J Med. 1986;80:435–442
  18. US Renal Data System. Excerpts from the 2007 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Am J Kidney Dis. 2008;51(suppl 1):S1–S319
  19. Kurella M, Chertow G, Fried L, et al. Chronic kidney disease and cognitive impairment in the elderly: The health, aging and body composition study. J Am Soc Nephrol. 2005;16:2127–2133
  20. Seliger S, Siscovick D, Stehman-Breen C, et al. Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study. J Am Soc Nephrol. 2004;15:1904–1911
  21. Shlipak M, Stehman-Breen C, Fried L, et al. The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kid Dis. 2004;43:861–867
  22. Keith D, Nicholls G, Guillion C, Brown J, Smith D. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Int Med. 2004;164:659–663
  23. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352:2049–2060
  24. Astor B, Hallan S, Miller E: Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol (in press)
  25. Steinman M, Landefeld C, Rosenthal G, et al. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc. 2006;54:16–23
  26. National Kidney Foundation. K/DOQI clinical practice guidelines for hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(suppl 1):S1–S268
  27. National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis. 2007;50:471–530
  28. National Kidney Foundation. K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis. 2000;35(suppl 2):S1–S140
  29. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(suppl 3):S1–S202
  30. Shlipak MG, Fried LF, Crump C, et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int. 2002;62:997–1004
  31. Paisley K, Beaman M, Tooke J, et al. Endothelial dysfunction and inflammation in asymptomatic proteinuria. Kidney Int. 2003;63:624–633
  32. Clausen P, Jensen J, Jensen G, Borch-Johnsen K, Feldt-Rasmussen B. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation. 2001;103:1869–1874
  33. Mitchell GF, Guo CY, Benjamin EJ, et al. Cross-sectional correlates of increased aortic stiffness in the community: the Framingham Heart Study. Circulation. 2007;115:2628–2636
  34. O’Rourke M, Safar ME. Relationship between aortic stiffness and microvascular disease. Hypertension. 2005;46:200–204
  35. Shlipak MG. Cystatin C: Research priorities targeted to clinical decision making. Am J Kid Dis. 2008;51:358–361
  36. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572
  37. American Diabetes Association. Standards of Medical Care in Diabetes—2006. Diabetes Care. 2006;29(suppl 1):S1–S71
  38. National Kidney Foundation. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(suppl 3):S1–S153
  39. National Kidney Foundation. K/DOQI clinical practice guidelines for management of dyslipidemias in chronic kidney disease. Am J Kidney Dis. 2003;41(suppl 3):S1–S92
  40. National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49(suppl 2):S1–S180
  41. Diabetes Project. Kidney Disease Initiative. http://www.cdc.gov/diabetes/projects/kidney.htm2007;Accessed January 9, 2008

PII: S0272-6386(08)00059-0

doi: 10.1053/j.ajkd.2008.01.009

American Journal of Kidney Diseases
Volume 51, Issue 3 , Pages 353-357 , March 2008

Article Tools

* Image Usage & Resolution